Keywords
LA/corticosteroid; intra-articular injection; low back pain; lumbar facet joint syndrome; platelet-rich plasma.
Summary
46 eligible patients with lumbar facet joint syndrome were randomized into group A (intra-articular injection with PRP) and group B (intra-articular injection with LA/corticosteroid). The following contents were evaluated: pain visual analog scale (VAS) at rest and during flexion, and the Roland-Morris Disability Questionnaire (RMQ), Oswestry Disability Index (ODI), and modified MacNab criteria for pain relief and applications of post-treatment drugs. All outcome assessments were performed immediately after and at 1 week, 1, 2, 3, and 6 months after treatment.
For group B, subjective satisfaction based on the modified MacNab criteria and objective success rate were highest (80% and 85%) after 1 month, but only 50% and 20% after 6 months. However, for group A, they increased over time. In addition, there were no treatment-related complications in either group during follow-up.
Both autologous PRP and LA/corticosteroid for intra-articular injection are effective, easy, and safe enough in the treatment of lumbar facet joint syndrome. However, autologous PRP is a superior treatment option for longer duration efficacy.
Support available at Surecell
Our Surecell doctors are musculoskeletal experts who provide regenerative medicine treatments for osteoarthritis, such as platelet-rich plasma (PRP). Feel free to contact our friendly staff on 03 9822 9996 from 8:00 AM - 7:00 PM or submit an enquiry here.
Learn more about the PRP treatments Surecell has to offer on our Services page, as well as other allied health services we provide.